Schizophrenia Research
Volume 81, Issue 2 , Pages 145-150 , 31 January 2006

Course of substance misuse and daily tobacco use in first-episode psychosis

  • Darryl Wade

      Affiliations

    • ORYGEN Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia
    • Department of Psychiatry, University of Melbourne, Parkville, VIC 3052, Australia
    • Corresponding Author InformationCorresponding author. ORYGEN Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia. Tel.: +61 3 9342 2800; fax: +61 3 9387 3003.
    • ,
  • Susy Harrigan

      Affiliations

    • ORYGEN Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia
    • Department of Psychiatry, University of Melbourne, Parkville, VIC 3052, Australia
    • ,
  • Jane Edwards

      Affiliations

    • ORYGEN Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia
    • Department of Psychiatry, University of Melbourne, Parkville, VIC 3052, Australia
    • ,
  • Philip M. Burgess

      Affiliations

    • School of Population Health, University of Queensland, Queensland Centre for Mental Health Research, Richlands, QLD 4077, Australia
    • ,
  • Greg Whelan

      Affiliations

    • Department of Medicine, University of Melbourne at St. Vincent's Hospital, Fitzroy, VIC 3065, Australia
    • ,
  • Patrick D. McGorry

      Affiliations

    • ORYGEN Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia
    • Department of Psychiatry, University of Melbourne, Parkville, VIC 3052, Australia

Received 16 July 2005 ,Revised 16 July 2005 ,Accepted 10 September 2005.

References 

  1. Addington J, Addington D. Impact of an early psychosis program on substance use. Psychiatr. Rehabil. J. 2001;25:60–67
  2. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa; 1981;
  3. Bartels SJ, Drake RE, Wallach MA. Long-term course of substance use disorders among patients with severe mental illness. Psychiatr. Serv. 1995;46:248–251
  4. Cuffel BJ, Chase P. Remission and relapse of substance use disorders in schizophrenia: results from a one-year prospective study. J. of Nerv. Ment. Dis. 1984;182:342–348
  5. Edwards J, Hinton M, Elkins K, Athanasopoulos A. Cannabis and first-episode psychosis: the CAP project. In:  Graham H,  Mueser KT,  Birchwood M,  Copello A editor. Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester: John Wiley & Sons; 2003;p. 283–304
  6. Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biol. Psychiatry. 1996;40:1155–1163
  7. Kavanagh DJ, Young R, White A, Saunders JB, Wallis J, Shockley N, et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug Alcohol Rev. 2004;23:151–155
  8. Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr. Bull. 1986;12:578–602
  9. McGorry PD, Singh BS, Copolov DL, Kaplan I, Dossetor CR, Van Riel RJ. Royal Park Multidiagnostic Instrument for Psychosis: Part II. Development, reliability, and validity. Schizophr. Bull. 1990;16:517–536
  10. McGovern MP, Morrison DH. The Chemical Use, Abuse, and Dependence Scale (CUAD): rationale, reliability, and validity. J. Subst. Abuse Treat. 1992;9:27–38
  11. Rabinowitz J, Bromet EJ, Carlson LG, Kovasznay B, Schwartz JE. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients. Psychol. Med. 1998;28:1411–1419
  12. Sorbara F, Liraud F, Assens F, Abalan F, Verdoux H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur. Psychiatr. 2003;18:133–136

☆ This paper was presented in part at the International Congress on Schizophrenia Research, Colorado Springs, Colorado, 2003.

PII: S0920-9964(05)00454-8

doi: 10.1016/j.schres.2005.09.010

Schizophrenia Research
Volume 81, Issue 2 , Pages 145-150 , 31 January 2006

Article Tools